UNSPSC 51112805: Toremifene

This classification denotes a selective estrogen receptor modulator with the molecular formula C26H28ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7NFE54O27T, chemically known as 2-(p-((z)-4-chloro-1,2-diphenyl-1-butenyl)phenoxy)-n,n-dimethylethylamine citrate (1:1) but more generally known as toremifene, which bears US NIH Compound Identifier 3005572. European Medicines Agency schedules Toremifene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11197MIG.

UNSPSC 51112805 Toremifene is a Commodity code that indexes procurement of toremifene citrate, a selective estrogen receptor modulator (SERM) used in oncology, specifically as a treatment for hormone receptor-positive breast cancer in postmenopausal women. State and local governments purchase this pharmaceutical through health departments, correctional health systems, public hospital networks, and Medicaid agencies. The drug is typically procured as a bulk pharmaceutical supply or through pharmacy benefit management contracts that cover inpatient and outpatient oncology departments within state and local health systems.

The source provides no recent state or local contract opportunities tagged to this code. Without posted RFP, RFQ, IFB, or ITB notices, geographic distribution and issuing-body concentration cannot be characterized. Procurement activity under toremifene may be bundled into broader pharmaceutical supply or oncology medication contracts rather than solicited as a standalone commodity, or opportunities may be posted through internal purchasing systems not captured in the available dataset.